Detalhe da pesquisa
1.
Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis.
Blood
; 143(13): 1259-1268, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194690
2.
Response rates to second-line treatment with daratumumab bortezomib dexamethasone (DVD) in relapsed/refractory light chain amyloidosis (AL) after initial Bortezomib-based regime.
Br J Haematol
; 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38840512
3.
Real-world efficacy of single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.
Br J Haematol
; 204(5): 1811-1815, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38171355
4.
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis.
Eur Heart J
; 44(24): 2187-2198, 2023 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36946431
5.
Linking changes in quality of life to haematologic response and survival in systemic immunoglobulin light-chain amyloidosis.
Br J Haematol
; 201(3): 422-431, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36709756
6.
Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis.
Eur Heart J
; 43(4): 333-341, 2022 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34472567
7.
Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment.
Eur Heart J
; 43(45): 4722-4735, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239754
8.
A UK consensus algorithm for early treatment modification in newly diagnosed systemic light-chain amyloidosis.
Br J Haematol
; 198(2): 328-332, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35509237
9.
Haematologic responses and survival do not significantly decrease with subsequent lines of therapy in systemic immunoglobulin light chain amyloidosis: results from an analysis of real-world longitudinal data.
Br J Haematol
; 194(3): 587-597, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34189728
10.
Urinary retinol binding protein predicts renal outcome in systemic immunoglobulin light-chain (AL) amyloidosis.
Br J Haematol
; 194(6): 1016-1023, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374069
11.
A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib.
Blood
; 134(25): 2271-2280, 2019 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31578202
12.
Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first-line treatment of systemic light chain amyloidosis in the UK.
Eur J Haematol
; 106(4): 537-545, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33460466
13.
Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis.
Eur Heart J
; 41(14): 1439-1447, 2020 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31950987
14.
Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis.
Circulation
; 140(1): 16-26, 2019 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31109193
15.
Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light-chain amyloidosis.
Br J Haematol
; 189(4): 643-649, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31984481
16.
Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria.
Haematologica
; 105(5): 1405-1413, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31399529
17.
Cytomegalovirus reactivation after bortezomib treatment for multiple myeloma and light chain amyloidosis.
Eur J Haematol
; 104(3): 230-235, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31815313
18.
The value of screening biopsies in light-chain (AL) and transthyretin (ATTR) amyloidosis.
Eur J Haematol
; 105(3): 352-356, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32495369
19.
Analysis of the TTR gene in the investigation of amyloidosis: A 25-year single UK center experience.
Hum Mutat
; 40(1): 90-96, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30328212
20.
Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy.
Br J Haematol
; 187(5): 638-641, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31388995